Shah Sujal
Insider CIK 1588861 · NONE President & CEO, Director · TVRD Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TVRD Tvardi Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TVRD Tvardi Therapeutics, Inc. | A Award deriv | 2025-04-17 | 2025-04-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TVRD Tvardi Therapeutics, Inc. | A Award deriv | 2025-04-15 | 2025-04-17 | 10,394 | — | $0 | 10,394 | SEC↗ |
| TVRD Tvardi Therapeutics, Inc. | A Award deriv | 2025-04-15 | 2025-04-17 | 8,047 | — | $0 | 8,047 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 88,351 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 39,375 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 50,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 47,916 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 90,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 621,101 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 146,875 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 314,120 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 536,032 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 284,712 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 649,999 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 800,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 357,500 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer | 2024-03-22 | 2024-03-22 | 96,250 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer | 2024-03-22 | 2024-03-22 | 310,420 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 18,899 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 11,649 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 2,288 | — | $0 | 12,845 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 22,076 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 14,372 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 3,125 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 1 | — | $0 | 35,799 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 52,084 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 14,625 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-03-13 | 2024-03-15 | 18,899 | $9.21 | $174.1K | 364,808 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-03-13 | 2024-03-15 | 52,084 | $1.72 | $89.6K | 345,909 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-03-13 | 2024-03-15 | 14,625 | $1.06 | $15.5K | 293,825 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-03-13 | 2024-03-15 | 11,649 | $10.00 | $116.5K | 279,200 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-03-13 | 2024-03-15 | 14,372 | $8.43 | $121.2K | 382,305 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-03-13 | 2024-03-15 | 22,076 | $4.05 | $89.4K | 404,381 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-03-13 | 2024-03-15 | 2,288 | $5.78 | $13.2K | 406,669 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-03-13 | 2024-03-15 | 1 | $2.94 | $3 | 406,670 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-03-13 | 2024-03-15 | 3,125 | $11.69 | $36.5K | 367,933 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2024-01-24 | 2024-01-26 | 357,500 | — | $0 | 357,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award | 2024-01-24 | 2024-01-26 | 96,250 | — | $0 | 267,551 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-12-11 | 2023-12-11 | 12,973 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-12-11 | 2023-12-11 | 20,856 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-12-11 | 2023-12-11 | 31,036 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-12-11 | 2023-12-11 | 890 | $5.00 | $4.5K | 172,191 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-12-11 | 2023-12-11 | 890 | $20.81 | $18.5K | 171,301 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-12-11 | 2023-12-11 | 63,975 | $19.99 | $1.28M | 171,301 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-12-11 | 2023-12-11 | 63,975 | $5.00 | $319.9K | 235,276 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-11-13 | 2023-11-14 | 31,036 | — | $0 | 31,036 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-11-13 | 2023-11-14 | 12,972 | — | $0 | 12,973 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-11-13 | 2023-11-14 | 20,855 | — | $0 | 20,856 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-11-13 | 2023-11-14 | 20,855 | $5.00 | $104.3K | 192,156 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-11-13 | 2023-11-14 | 20,855 | $15.89 | $331.4K | 171,301 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-11-13 | 2023-11-14 | 44,008 | $15.89 | $699.3K | 171,301 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-11-13 | 2023-11-14 | 44,008 | $5.00 | $220.0K | 215,309 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-10-09 | 2023-10-10 | 12,972 | — | $0 | 25,945 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-10-09 | 2023-10-10 | 20,855 | — | $0 | 41,711 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-10-09 | 2023-10-10 | 31,034 | — | $0 | 62,072 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-10-09 | 2023-10-10 | 64,861 | $5.00 | $324.3K | 236,162 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-10-09 | 2023-10-10 | 64,861 | $14.20 | $921.0K | 171,301 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2023-01-25 | 2023-01-27 | 800,000 | — | $0 | 800,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2022-06-06 | 2022-06-07 | 51,301 | $1.95 | $100.0K | 171,301 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 650,000 | — | $0 | 650,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 287,000 | — | $0 | 287,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 558,108 | — | $0 | 558,108 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2019-10-10 | 2019-10-15 | 5,000 | $4.30 | $21.5K | 120,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2019-09-23 | 2019-09-24 | 3,100 | $5.55 | $17.2K | 115,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2019-09-20 | 2019-09-24 | 1,900 | $5.50 | $10.4K | 111,900 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2019-01-29 | 2019-01-31 | 328,492 | — | $0 | 328,492 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2018-12-21 | 2018-12-21 | 10,000 | $6.54 | $65.4K | 110,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2018-10-15 | 2018-10-16 | 5,000 | $9.90 | $49.5K | 100,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2018-07-27 | 2018-07-30 | 5,000 | $10.90 | $54.5K | 95,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2018-05-11 | 2018-05-15 | 5,000 | $10.65 | $53.3K | 90,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-10-27 | 2017-10-31 | 640,000 | — | $0 | 640,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-07-20 | 2017-07-24 | 8,033 | $7.35 | $59.0K | 85,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-07-20 | 2017-07-24 | 891 | $7.29 | $6.5K | 75,891 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-07-20 | 2017-07-24 | 400 | $7.30 | $2.9K | 76,291 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-07-20 | 2017-07-24 | 576 | $7.31 | $4.2K | 76,867 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2017-07-20 | 2017-07-24 | 100 | $7.32 | $732 | 76,967 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-04-27 | 2017-05-01 | 90,000 | — | $0 | 90,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-01-19 | 2017-01-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-01-04 | 2017-01-06 | 25,000 | — | $0 | 50,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2016-12-30 | 2017-01-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2016-04-05 | 2016-04-06 | 33,000 | $1.39 | $45.9K | 75,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2016-04-04 | 2016-04-06 | 22,000 | $1.39 | $30.6K | 42,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2016-01-26 | 2016-01-28 | 54,000 | — | $0 | 54,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | P Buy | 2015-05-18 | 2015-05-19 | 10,000 | $3.40 | $34.0K | 20,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2015-01-07 | 2015-01-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | P Buy | 2014-09-16 | 2014-09-17 | 10,000 | $7.44 | $74.4K | 10,000 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2014-01-06 | 2014-01-08 | 62,566 | — | $0 | 62,566 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 93,106 | — | $0 | 93,106 | SEC↗ |
| NONE CymaBay Therapeutics, Inc. | A Award deriv | 2013-12-23 | 2013-12-27 | 38,917 | — | $0 | 38,917 | SEC↗ |